Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans

Clinical trial NCT02225184 · COMPLETED

Trial details

NCT number: NCT02225184
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Study type: OBSERVATIONAL

Genetic Underpinning of Substance Abuse Polymorphism-genetic Drug Abuse/Dependence Opiod-Related Disorders

Start date: 2014-08-23
Primary completion: 2018-12-31
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.